Inventor
WANG GUOQUAN
US18 patents
⚠️ This page may combine multiple inventors who share the name “WANG GUOQUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PGX HEALTH LLC
4 patentsUS7598379B2Oct 6, 2009
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
PGX HEALTH LLC14 citations92
US7732455B2Jun 8, 2010
Substituted 8-heteroaryl xanthines
PGX HEALTH LLC12 citations83
US7618962B2Nov 17, 2009
Pyrazolyl substituted xanthines
PGX HEALTH LLC16 citations83
US7601723B2Oct 13, 2009
Pyridyl substituted xanthines
PGX HEALTH LLC17 citations83
WANG GUOQUAN
4 patentsUS8153628B2Apr 10, 2012
Pyrazolyl substituted xanthines
WANG GUOQUAN2 citations61
US8501941B2Aug 6, 2013
Methods for the synthesis of unsymmetrical cycloakyl substituted xanthines
WANG GUOQUAN0 citations50
US8420813B2Apr 16, 2013
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
WANG GUOQUAN0 citations50
US8258142B2Sep 4, 2012
Substituted 8-[6-amino-3-pyridyl]xanthines
WANG GUOQUAN0 citations50
LEWIS AND CLARK PHARMACEUTICALS INC
3 patentsUS9067963B2Jun 30, 2015
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
LEWIS AND CLARK PHARMACEUTICALS INC30 citations91
US9822141B2Nov 21, 2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
LEWIS AND CLARK PHARMACEUTICALS INC1 citations49
US9593118B2Mar 14, 2017
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists
LEWIS AND CLARK PHARMACEUTICALS INC0 citations39